Prof. Xiaofang Wang 王晓芳
Chief Physician, Professor
Department of Hematology, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of malignant lymphoma, multiple myeloma, and acute and chronic leukemia, including refractory and recurrent cases using CAR-T and hematopoietic stem cell transplantation.
Dr. Wang is a Chief Physician, Professor, and attending physician with a medical doctorate from Fudan University. Dr. Wang serves as a master's supervisor and conducts research on the basic science and clinical treatment of multiple myeloma and lymphoma.
Name order: in Chinese the family name comes first (Wang Xiaofang). Papers usually list the name as Xiaofang Wang or Wang X.
Selected publications
39 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- Discov Oncol, 2025 (senior author): Ferroptotic resistance involved in PTEN-loss prostate cancer progression. PubMed 41288888
- Discov Oncol, 2025 (senior author): p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma. PubMed 40618312
- Ann Hematol, 2025 (senior author): Follicular lymphoma grade 3A: aggressiveness and curability in an Asian cohort of 781 patients. PubMed 40204934
- J Cancer, 2023 (senior author): FDG-PET/CT Provides Clues on Bone Marrow Involvement in Follicular Lymphoma and Carries Important Prognostic Information. PubMed 37779879
- Front Genet, 2022 (senior author): Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker. PubMed 36685968
- Oncol Lett, 2020 (first author): miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma. PubMed 32269622
- Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2019 (first author): [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma]. PubMed 30738447
- Oncol Lett, 2018 (senior author): ILK promotes angiogenic activity of mesenchymal stem cells in multiple myeloma. PubMed 29963187
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion